Avadel Pharmaceuticals Plc (AVDL)

Stock price, financials, and technical signals for Avadel Pharmaceuticals Plc (AVDL).

Twitter
Facebook
Email
FinancialsNews & SentimentProCandlestick ProbabilityElite

$6.80

-0.40

(-5.56%)

As of 04/04/2025 5:00 PM ET • Disclaimer
Powered by Stocksift.com

100%

AVDL Performance Snapshot

1-Week Chg

-15.11%

1-Month Chg

-10.99%

3-Month Chg

-38.52%

6-Month Chg

-48.05%

1-Year Chg

-59.01%

Year-To-Date Chg

-38.18%

Beta 1-Year

1.02

Beta 5-Year

1.51

Volatility (10-Day)

6.47%

AVDL Technicals

Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-04-04

$6.80

-$0.40 (-5.56%)

$7

$7.07

$6.60

$6.82

1.17M ($7.96M)

2025-04-03

$7.20

-$0.26 (-3.49%)

$7.29

$7.39

$7.07

$7.22

1.07M ($7.73M)

2025-04-02

$7.46

-$0.05 (-0.67%)

$7.42

$7.59

$7.31

$7.45

972.32K ($7.25M)

2025-04-01

$7.51

-$0.32 (-4.09%)

$7.73

$7.75

$7.42

$7.56

880.14K ($6.61M)

2025-03-31

$7.83

-$0.18 (-2.25%)

$7.99

$8.05

$7.76

$7.88

689.91K ($5.40M)

2025-03-28

$8.01

-$0.11 (-1.35%)

$8.19

$8.30

$7.89

$8.07

677.42K ($5.43M)

2025-03-27

$8.12

-$0.05 (-0.61%)

$8.16

$8.29

$8

$8.14

492.22K ($4.00M)

2025-03-26

$8.17

-$0.03 (-0.37%)

$8.20

$8.30

$7.98

$8.15

922.62K ($7.54M)

2025-03-25

$8.20

-$0.33 (-3.87%)

$8.49

$8.64

$8.17

$8.34

629.82K ($5.16M)

2025-03-24

$8.53

-$0.04 (-0.47%)

$8.68

$8.68

$8.42

$8.54

658.40K ($5.62M)

AVDL Financials

Balance Sheet

(USD)

2024 Q4

Y/Y CHANGE

  • Cash and equivalents

    $51.37M

    64.82%

  • Total assets

    $164.24M

    -0.28%

  • Total liabilities

    $90.39M

    17.45%

  • Total investments

    $22.41M

    -69.70%

  • Shareholders' equity

    $73.85M

    -15.83%

  • Book value per share

    $0.77

    -21.52%

Income Statement

(USD)

2024 Q4

Y/Y CHANGE

  • Revenue

    $50.41M

    159.14%

  • Net income

    -$5.04M

    82.48%

  • Operating expense

    $48.90M

    11.99%

  • Gross profit

    $45.60M

    143.06%

  • EBITDA

    -$1.59M

    94.00%

  • Earnings per share

    -$0.05

    82.76%

Cash Flow

(USD)

2024 Q4

Y/Y CHANGE

  • Net change in cash

    $22.79M

    210.39%

  • Cash from operations

    $7.87M

    128.09%

  • Cash from investing

    $14.91M

    -46.60%

  • Cash from financing

    $880.00K

    104.17%

  • Free cash flow

    $7.87M

    128.09%

  • Free cash flow per share

    $0.08

    126.28%

Metrics

(USD)

2024 Q4

Y/Y CHANGE

  • Market capitalization

    $1.01B

    -20.13%

  • Enterprise value

    $1.02B

    -19.73%

  • Shares outstanding

    96.36M

    7.30%

  • Profit margin

    -10.00%

    93.24%

  • Gross margin

    90.50%

    -6.12%

  • EBITDA margin

    -3.20%

    97.66%

Dividends

(USD)

2024 Q4

Y/Y CHANGE

  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    2.75

    -24.53%

View All Financials